Ind-Swift Laboratories is planning to raise funds through allotment of Non-Convertible Debentures (NCDs) to the prospective allottees on private placement basis through EBP Mechanism. The meeting of the Board of Directors of the company will be held on June 13, 2018, to consider the same.
Ind-Swift Laboratories has manufacturing sites at 6 different locations across India and an independent State-of-the-Art R&D Centre, the Group has embarked upon a journey to establish itself as reliable partner in the Global Pharmaceutical Industry.
